Vienna was the grand setting of the 13th Annual BIO-Europe Spring partnering meeting at the Congress Centre Wien, with receptions at the Hofburg Palace and the Rathaus. Thousands of biopharma executives congregated for one-to-one meetings to discuss collaborations, investment and the in- and outlicensing of assets. The three-day conference agenda included plenary sessions, company presentations, panel discussions, partnering workshops, networking lunches and spotlight sessions. Topics of focus included the Asia-Pacific evolving biopharma landscape, investment and partnering emerging opportunities in metabesity and nonalcoholic steatohepatitis, the biopharma value chain transformation through digital technologies, microbiome therapeutics deals and upcoming trends in European biotech. This report covers highlights from the meeting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1358/dot.2019.55.5.2996481 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BIO-Europe Spring 2019 - 13th Annual International Partnering Conference (March 25-27, 2019 - Vienna, Austria).
Drugs Today (Barc)
May 2019
Clarivate Analytics, London, UK.
Vienna was the grand setting of the 13th Annual BIO-Europe Spring partnering meeting at the Congress Centre Wien, with receptions at the Hofburg Palace and the Rathaus. Thousands of biopharma executives congregated for one-to-one meetings to discuss collaborations, investment and the in- and outlicensing of assets. The three-day conference agenda included plenary sessions, company presentations, panel discussions, partnering workshops, networking lunches and spotlight sessions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!